Student Name
Capella University
NURS-FPX 6021 Biopsychosocial Concepts for Advanced Nursing Practice 1
Prof. Name
Date
Change Strategy and Implementation
Renal failure is a clinical condition in which the kidneys lose their ability to adequately filter metabolic waste and regulate fluid balance, resulting in systemic physiological disturbances (Nagendra et al., 2023). This paper develops a patient-centered intervention plan for Mrs. Smith, a 52-year-old individual diagnosed with Type II Diabetes Mellitus and Acute Renal Failure (Capella University, 2024). The proposed strategy integrates evidence-based clinical practices with coordinated interprofessional care to enhance patient safety, promote equitable access, and improve overall health outcomes. Emphasis is placed on individualized care planning aligned with current standards from authoritative bodies such as the American Diabetes Association (ADA) and NANDA.
Data Table
The following table synthesizes Mrs. Smith’s current clinical indicators, target health outcomes, and measurable improvement goals. These benchmarks are derived from established clinical guidelines and uphold patient confidentiality in accordance with HIPAA regulations.
Table 1: Clinical Outcomes Assessment
| Clinical Outcome | Current State | Desired State | Target Improvement |
|---|---|---|---|
| Blood Glucose Levels | Fasting: 125 mg/dL; Postprandial: 140 mg/dL; intermittent spikes (200–350 mg/dL); ~60% incidence of insulin variability | Fasting: 80–130 mg/dL; Postprandial: <180 mg/dL | 50% reduction in glycemic excursions (Lin et al., 2021) |
| Renal Function | Presence of mild peripheral edema; early renal impairment indicated in labs; ~30% prevalence | Absence of edema; stabilized renal markers; normal urine output | 20% improvement in renal indicators (ADA, 2022) |
| Self-Care & Social Support | Irregular dietary adherence; reliance on family member; limited social engagement; ~40% self-care deficit | Consistent dietary compliance; improved independence and social participation | 95% improvement in self-management capacity (Martens et al., 2021) |
| Medication Adherence | Financial barriers impacting compliance; ~70% affected | Sustained adherence; reduced financial burden | 90% access to financial assistance (Laursen et al., 2021) |
Areas of Ambiguity and Uncertainty
Several aspects of Mrs. Smith’s condition require further clarification to refine the care plan. Specifically, more detailed insights into her nutritional habits, physical activity levels, and medication adherence patterns are necessary to identify contributors to glycemic instability. Additionally, a deeper assessment of her socioeconomic challenges and available support systems would enable the design of targeted, context-sensitive interventions (Lin et al., 2021). Addressing these uncertainties is essential for improving care precision and effectiveness.
Change Strategies for Desired Outcomes
The implementation of Continuous Glucose Monitoring (CGM) represents a critical intervention for maintaining glycemic stability. This technology allows real-time tracking of blood glucose levels, facilitating timely therapeutic adjustments. When combined with structured diabetes self-management education focusing on nutrition and lifestyle modification, CGM can significantly reduce glycemic variability (Martens et al., 2021).
To address renal complications, pharmacological management using prescribed diuretics should be complemented by continuous monitoring of renal parameters. Early detection of deterioration and collaboration with nephrology specialists are expected to yield measurable improvements in kidney function (ADA, 2022).
Improving self-care capacity requires a multifaceted approach involving:
- Dietary counseling led by registered dietitians
- Increased engagement in community-based support programs
- Structured patient education workshops
NURS FPX 6021 Assessment 2 Change Strategy and Implementation
These interventions aim to enhance independence and promote sustained behavioral change (Do et al., 2020).
Financial constraints can be mitigated through enrollment in medication assistance programs and optimization of treatment regimens to reduce cost burden. At a broader level, partnerships with community organizations can improve access to resources, thereby strengthening medication adherence rates (Laursen et al., 2021).
A multidisciplinary care team—including endocrinologists, nurses, dietitians, nephrologists, and social workers—will oversee implementation and continuously evaluate patient progress. Potential barriers such as resistance to lifestyle adjustments and economic limitations can be addressed through family involvement and community resource utilization (Sugandh et al., 2023).
Justification of the Change Strategies
The adoption of CGM is supported by strong clinical evidence demonstrating its effectiveness in optimizing glycemic control and reducing acute complications through continuous feedback mechanisms (ADA, 2022). Similarly, structured dietary education has been shown to significantly improve metabolic outcomes in diabetic populations (Martens et al., 2021).
Diuretics play a vital role in managing fluid overload and preventing progression of renal dysfunction (Afify et al., 2023). Furthermore, financial assistance initiatives directly influence adherence behaviors by alleviating economic barriers, a well-documented determinant of treatment success (Kvarnström et al., 2021).
Alternative supportive strategies include:
- Renal-specific dietary modifications
- Integration of mental health support to enhance adherence
These approaches ensure a comprehensive, patient-centered framework that accounts for both clinical and psychosocial determinants of health (Karakuş et al., 2021; Bingham et al., 2020).
Quality Improvement in Safety and Equitable Care through Change Strategies
The integration of CGM enhances patient safety by enabling early detection of hyperglycemic and hypoglycemic events, thereby reducing the likelihood of acute complications such as diabetic ketoacidosis (Martens et al., 2021). Concurrently, diuretic therapy supports fluid balance and protects renal function, minimizing the risk of disease progression (Afify et al., 2023).
Improved dietary practices and increased social engagement contribute to better self-management, ultimately lowering complication rates and improving quality of life. From an equity perspective, financial support mechanisms ensure that patients can access essential medications regardless of socioeconomic status, thereby narrowing healthcare disparities (Kvarnström et al., 2021).
These strategies collectively align with the Quadruple Aim framework by:
- Enhancing patient experience
- Improving population health
- Reducing healthcare costs
- Supporting provider well-being (Clark et al., 2022)
How Change Strategies Will Utilize Interprofessional Considerations
Effective implementation of the proposed interventions depends on strong interprofessional collaboration. Endocrinologists oversee glycemic management, nurses provide patient education and monitoring, dietitians guide nutritional planning, and social workers address psychosocial and financial barriers (Martens et al., 2021; Ernawati et al., 2021).
This coordinated approach ensures:
- Continuity of care
- Timely clinical decision-making
- Comprehensive patient support
Additionally, distributing responsibilities across the care team reduces provider workload and mitigates burnout, fostering a sustainable healthcare environment (Ernawati et al., 2021). Successful execution assumes adequate access to trained personnel and necessary technological resources such as CGM systems (Nurchis et al., 2022).
Conclusion
The integration of advanced glucose monitoring, targeted education, and financial support mechanisms provides a robust framework for improving Mrs. Smith’s clinical outcomes. These interventions not only enhance patient safety and promote equitable care but also strengthen interprofessional collaboration. Ultimately, this comprehensive strategy supports long-term disease management, reduces complication risks, and improves both patient and provider well-being.
References
ADA. (2022). American Diabetes Association. Diabetes.org. https://diabetes.org/
Afify, H., Morales, U. G., Asmar, A., Alvarez, C. A., & Mansi, I. A. (2023). Association of thiazide diuretics with diabetes progression, kidney disease progression, cardiovascular outcomes, and death among patients with diabetes who initiate statins. The American Journal of Cardiology, 203, 274–284. https://doi.org/10.1016/j.amjcard.2023.07.057
Bingham, J. M., Black, M., Anderson, E. J., Li, Y., Toselli, N., Fox, S., Martin, J. R., Axon, D. R., & Silva-Almodóvar, A. (2020). Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: A systematic review. Annals of Pharmacotherapy, 55(5), 637–649. https://doi.org/10.1177/1060028020950726
Capella University. (2024). Capella University: Online accredited degree programs. https://www.capella.edu/
NURS FPX 6021 Assessment 2 Change Strategy and Implementation
Clark, A., Jung, E., Prusky, C., Shah, B. R., & Halperin, I. J. (2022). Evaluation of virtual care for gestational diabetes using the quadruple aim framework. Canadian Journal of Diabetes, 47(3), 236–242. https://doi.org/10.1016/j.jcjd.2022.12.002
Do, J. Y., Kim, S. W., Park, J. W., Cho, K. H., & Kang, S. H. (2020). Association between metformin use and clinical outcomes in diabetes patients. Diabetes & Metabolism, 47(4). https://doi.org/10.1016/j.diabet.2020.10.006
Ernawati, U., Wihastuti, T. A., & Utami, Y. W. (2021). Effectiveness of diabetes self-management education in T2DM patients. Journal of Public Health Research, 10(2), 198–202. https://doi.org/10.4081/jphr.2021.2240
Karakuş, K. E., et al. (2021). Benefits and drawbacks of continuous glucose monitoring. Journal of Patient Experience, 8(1). https://doi.org/10.1177/23743735211056523
NURS FPX 6021 Assessment 2 Change Strategy and Implementation
Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021). Factors contributing to medication adherence. Pharmaceutics, 13(7). https://doi.org/10.3390/pharmaceutics13071100
Laursen, J., et al. (2021). Effects of dapagliflozin on renal outcomes. EClinicalMedicine, 37. https://doi.org/10.1016/j.eclinm.2021.100895
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021). Continuous glucose monitoring in diabetes. Diabetic Medicine, 38(5). https://doi.org/10.1111/dme.14528
Martens, T., et al. (2021). Effect of CGM on glycemic control. JAMA, 325(22). https://doi.org/10.1001/jama.2021.7444
Nagendra, L., Fernandez, C. J., & Pappachan, J. M. (2023). Kidney transplantation perspectives. World Journal of Transplantation, 13(5), 208–220. https://doi.org/10.5500/wjt.v13.i5.208
NANDA. (2020). NANDA International Nursing Diagnoses. https://nanda.org/
NURS FPX 6021 Assessment 2 Change Strategy and Implementation
Nurchis, M. C., et al. (2022). Interprofessional collaboration in diabetes care. Journal of Personalized Medicine, 12(4). https://doi.org/10.3390/jpm12040643
Sugandh, F. N. U., et al. (2023). Advances in diabetes management. Cureus, 15(8), 1–13. https://doi.org/10.7759/cureus.43697